Achieve Life Sciences, Inc. (NASDAQ: ACHV) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $18.00 to $11.00. They now have an "outperform" rating on the stock.
MediumReport
Achieve Life Sciences, Inc. (NASDAQ: ACHV) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $18.00 to $11.00. They now have an "outperform" rating on the stock.
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine [Financial Post (Toronto, Ontario, Canada)]
LowReport
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine [Financial Post (Toronto, Ontario, Canada)]
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: